Javascript must be enabled to continue!
Research on Shift Strategy in the Econopower Racing Car
View through CrossRef
<div class="htmlview paragraph">This paper discussed the shift strategy of Yanshan University econopower racing car in the 2007. The writer made the power train and the manual shift device on the base of the assembly of the engine and the transmission provided by the organizer of the Honda -China Econopower Racing competition. The writer also set down some shift strategies combining the mechanical performance of the racing car and does much experiment on car racing with different gear on the road which is almost the same with the real competition road, at last the writer reached a conclusion that how to drive the racing car with proper gear. The conclusion will guide the writer to do well in the improvement of the mechanical structure and the strategy of driving the racing car.</div>
Title: Research on Shift Strategy in the Econopower Racing Car
Description:
<div class="htmlview paragraph">This paper discussed the shift strategy of Yanshan University econopower racing car in the 2007.
The writer made the power train and the manual shift device on the base of the assembly of the engine and the transmission provided by the organizer of the Honda -China Econopower Racing competition.
The writer also set down some shift strategies combining the mechanical performance of the racing car and does much experiment on car racing with different gear on the road which is almost the same with the real competition road, at last the writer reached a conclusion that how to drive the racing car with proper gear.
The conclusion will guide the writer to do well in the improvement of the mechanical structure and the strategy of driving the racing car.
</div>.
Related Results
Racing Simulacra?
Racing Simulacra?
"So which is the most authentic experience for an end-user steeped in car culture? Real, made-in-Japan Type R? Or virtual, programmed-in-Japan Type-R. Each Type-R is equally enjoya...
Study on Effects of Driving Style on Vehicle Performance for Econopower Competition
Study on Effects of Driving Style on Vehicle Performance for Econopower Competition
<div class="htmlview paragraph">According to the 2007 Honda China Econopower Competition regulation, the effects of driving style on the econopower performance of econopower ...
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
Abstract
Background
Epetraborole (EBO) is an orally available, bacterial leucyl transfer RNA synthetase inhibitor that concentra...
PERBANDINGAN UNJUK KERJA DAN KONSUMSI BAHAN BAKAR ANTARA MOTOR YANG MEMPERGUNAKAN KOIL STANDAR DAN BUSI STANDAR DENGAN MOTOR YANG MEMPERGUNAKAN KOIL RACING DAN BUSI RACING MENGGUNAKAN BAHAN BAKAR PERTAMAX
PERBANDINGAN UNJUK KERJA DAN KONSUMSI BAHAN BAKAR ANTARA MOTOR YANG MEMPERGUNAKAN KOIL STANDAR DAN BUSI STANDAR DENGAN MOTOR YANG MEMPERGUNAKAN KOIL RACING DAN BUSI RACING MENGGUNAKAN BAHAN BAKAR PERTAMAX
Tujuan dari penelitian ini adalah untuk mengetahui performa mesin dengan membandingkan sistem pengapian antara penggunaan koil standar dan busi standar dengan koil racing dan busi ...
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
Abstract
Background
SUL-DUR is a β-lactam/β-lactamase inhibitor combination in development for the treatment of ABC infections, ...
Functional Diversification and Dynamics of CAR-T Cells in B-ALL Patients
Functional Diversification and Dynamics of CAR-T Cells in B-ALL Patients
Chimeric antigen receptor-engineered (CAR)-T cell therapy represents one of the most promising strategies of cancer treatment, and the function and persistence of CAR-T cells in vi...
Potent Anti-Tumor Activity of Bcma CAR-T Therapy Against Heavily Treated Multiple Myeloma and Dynamics of Immune Cell Subsets Using Single-Cell Mass Cytometry
Potent Anti-Tumor Activity of Bcma CAR-T Therapy Against Heavily Treated Multiple Myeloma and Dynamics of Immune Cell Subsets Using Single-Cell Mass Cytometry
Background BCMA CAR-T cells have demonstrated substantial clinical activity against relapsed/refractory multiple myeloma (RRMM). In different clinical trials, the overall response ...
Key Findings from a Transformative Quality Improvement Initiative on Advancing CAR T-Cell Treatment in Non-Hodgkin Lymphoma
Key Findings from a Transformative Quality Improvement Initiative on Advancing CAR T-Cell Treatment in Non-Hodgkin Lymphoma
Background
Chimeric antigen receptor (CAR) T-cell therapy can transform outcomes for eligible patients with relapsed/refractory non-Hodgkin lymphoma (NHL). However, ...

